RE: FDA under pressure29 Aug 2020 10:03
Scope - A discussion with this committee, made up of outside scientific and public health experts from around the country, will help ensure clear public understanding regarding clinical development of these vaccines indicated to prevent COVID-19 and the data needed to facilitate their authorization or licensure. It is critical for people to see FDA’s expectations for data to support safety and effectiveness.
Sounds like public defence of the process and explain delays to me?